Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MOTIVATE 2: Maraviroc in Treatment-Experienced HIV-1
NCT00098722Phase 3Completed
- Sponsor
- ViiV Healthcare
- Start
- Dec 2004
- Primary completion
- Apr 2007
- Modality
- Small Molecules
- Countries
- 13
01
Overview
A Phase 3 trial of maraviroc in human immunodeficiency virus type 1 infection (HIV-1), sponsored by ViiV Healthcare. Started Dec 2004; status: completed.
02
Drugs
maraviroc
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00098722.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00098722.